mission-t1d_sanofi_game

Sanofi releases new diabetes app for children

pharmafile | September 5, 2014 | News story | Medical Communications, Sales and Marketing Gamification, Lilly board game, Sanofi, Syrum, monster manor 

Sanofi Diabetes has launched a new mobile game aimed at educating children, teachers, parents and carers about living with type 1 diabetes at school.

In ‘Mission T1D’, players make their way through a number of levels by earning points, with each level containing short illustrated messages and educational videos about living with type I diabetes (T1D).  

Topics of the videos include ‘Everyday life with T1D’ and ‘How to have a healthy diet’. There is also a quiz that tests children’s knowledge and understanding of living with T1D.

Sanofi says that it also intends the app and quiz to be used in a classroom setting to spread wider understanding about T1D among the peers of children with diabetes.

Rebecca Reeve, head of professional relations at Sanofi Diabetes, says: “We are committed to making a difference to the lives of children who are struggling with the challenge of managing diabetes, especially in an environment where they can easily be made to feel different.”

Sanofi is one of the world’s largest insulin manufacturers, with its biggest seller Lantus making around $8 billion a year – although recently Lantus has been outmatched in clinical trials by Lilly’s basal.

The French firm is one of several pharma companies who have tried out gamification. One of the first examples was Boehringer Ingelheim’s Facebook game Syrum.

This has since been followed by efforts from companies such as Cancer Research UK and Lilly – although Lilly’s online board game ‘Destination Discovery’ has been criticised by analyst Donald Light as providing ‘misinformation’ in the guise of ‘right answers’.

These games often provide a new method of delivering disease awareness campaigns to the public, which act as an alternative way of communicating with patients about a company’s work in regions where they are unable to directly advertise their products to patients.

This is not even the first diabetes-related game from Sanofi – last year the company released ‘Monster Manor’, an app where children with diabetes were rewarded for testing themselves more regularly.

The game has been shortlisted in the in the Health Service Journal (HSJ) Value in Healthcare Awards. Mission T1D is now available for free on Apple’s iOS, Android and PC devices.

George Underwood

Related Content

Sanofi shares phase 2b results for dermatitis treatment

Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study …

Sanofi to acquire Inhibrx for approximately $1.7bn

Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for …

AstraZeneca and Sanofi’s Beyfortus approved in China

AstraZeneca and Sanofi have announced that Beyfortus (nirsevimab) has been approved in China for the …

Latest content